Merck will assess Quris’ AI ‘patient-on-a-chip’ drug safety
German drugmaker Merck KGaA has reached an agreement to pilot an artificial intelligence platform developed by Quris that aims to identify potential safety problems with […]
Toxicology
What mRNA is Good For, And What It Maybe Isn’t
The huge success of the mRNA vaccination platform during the pandemic has set a lot of people to thinking about what comes next. Moderna and […]
Drug Repurposing for Coronaviruses: Be Careful
Here’s a new paper (open access) from a large multi-center team of authors urging caution on many of the reports of small-molecule repurposing screens against […]
The Novavax Vaccine Data, and Spike Proteins in General
1. Novavax Clinical Data Word came yesterday that Novavax had very good safety and efficacy in the trial of their recombinant protein vaccine. This is good […]
2nd Gene Therapy Immunogenicity
The 2nd Gene Therapy Immunogenicity Summit is the industry’s definitive forum enabling you to better modulate, measure and predict immune response to your gene therapy candidate. In the […]
Blood Clots and the AZ Vaccine, Revisited
Once again, what’s going on with vascular events and the AZ/Oxford vaccine? I last wrote about this situation a couple of weeks ago, and it’s […]
